A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
About This Bill
Committee
Latest Action · May 14, 2026
Referred to the Committee on Health, Education, Labor, and Pensions.
This Senate resolution expresses support for the safety and effectiveness of mifepristone, a medication used for abortion and miscarriage management, based on over 25 years of scientific evidence and hundreds of peer-reviewed studies. The resolution calls for abortion-related laws and policies to be based on scientific evidence rather than politics, and emphasizes that the Food and Drug Administration should be allowed to regulate the drug without political interference. The measure notes that mifepristone is currently used in over 90 countries and accounts for 63 percent of abortions in the United States, and that it has been approved for mail and pharmacy dispensing since 2023 after FDA review determined it remained safe through those methods. The resolution also highlights concerns about access disparities, arguing that restrictions on medication abortion disproportionately harm Black and Indigenous people, people of color, immigrants, people with lower incomes, rural residents, and other marginalized groups. As a resolution expressing the Senate's sense, this measure does not have the force of law and requires no presidential action or funding.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.